| scholarly article | Q13442814 |
| P50 | author | Nicola J Smith | Q57199403 |
| P2093 | author name string | James L J Coleman | |
| Margaret A Mouat | |||
| P2860 | cites work | Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk | Q45757541 |
| Hormone therapy modulates ET(A) mRNA expression in the aorta of ovariectomised New Zealand White rabbits | Q46060638 | ||
| Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation | Q46331177 | ||
| Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits | Q46813433 | ||
| Virtual and biomolecular screening converge on a selective agonist for GPR30. | Q46978096 | ||
| The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. | Q47139831 | ||
| The effects of gender on adrenergic receptor responsiveness | Q47692321 | ||
| Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system | Q48182878 | ||
| Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. | Q50890027 | ||
| Gender-related differences in androgen regulation of thromboxane A2 receptors in rat aortic smooth-muscle cells. | Q50959187 | ||
| Role of microsomal prostaglandin E synthase 1 in the kidney. | Q51756533 | ||
| Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats. | Q51801992 | ||
| Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. | Q52536351 | ||
| Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. | Q52913915 | ||
| EP(1) and EP(4) receptors mediate prostaglandin E(2) actions in the microcirculation of rat kidney. | Q54036124 | ||
| GPR30 Expression Is Required for the Mineralocorticoid Receptor–Independent Rapid Vascular Effects of Aldosterone | Q61772039 | ||
| Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells | Q67901926 | ||
| 17 beta-Estradiol inhibits Ca2+ influx and Ca2+ release induced by thromboxane A2 in porcine coronary artery | Q72220340 | ||
| 17 beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells | Q72299142 | ||
| Clearance of circulating endothelin-1 by ETB receptors in rats | Q72340095 | ||
| U 46619 induces different blood pressure effects in male and female spontaneously hypertensive rats (SHR) | Q72857920 | ||
| Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system | Q73371712 | ||
| Role of female sex hormones in the development and reversal of dahl hypertension | Q73371715 | ||
| Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells | Q74064560 | ||
| Vasoconstriction induced by G1, a G-protein-coupled oestrogen receptor1 (GPER-1) agonist, in the isolated perfused rat kidney | Q86045780 | ||
| Plasma endothelin-1 and cardiovascular risk among young and healthy adults | Q86591697 | ||
| Testosterone Increases Human Platelet Thromboxane A2 Receptor Density and Aggregation Responses | Q22306390 | ||
| A transmembrane intracellular estrogen receptor mediates rapid cell signaling | Q24294726 | ||
| RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75 | Q24304443 | ||
| G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation | Q24307603 | ||
| Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells | Q24314404 | ||
| A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22) | Q24681542 | ||
| Endothelin | Q26767156 | ||
| Estrogen production and action | Q28213624 | ||
| A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women | Q28218670 | ||
| The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha | Q28238281 | ||
| Cytochrome P450 eicosanoids in hypertension and renal disease | Q28252210 | ||
| The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure | Q28346548 | ||
| Renal medullary ETB receptors produce diuresis and natriuresis via NOS1 | Q28564721 | ||
| Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension | Q28567826 | ||
| Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation | Q28579205 | ||
| Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats | Q29347039 | ||
| Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF | Q29615227 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Proteomics. Tissue-based map of the human proteome | Q29617248 | ||
| A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
| Selected contribution: Gender differences in the endothelin-B receptor contribution to basal cutaneous vascular tone in humans | Q30749210 | ||
| G protein-coupled prostanoid receptors and the kidney | Q31963761 | ||
| Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism | Q32072303 | ||
| Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. | Q33675630 | ||
| Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults | Q33686561 | ||
| In vivo effects of a GPR30 antagonist | Q33828472 | ||
| Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension | Q33943987 | ||
| Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis | Q34107645 | ||
| Isolated human and rat cerebral arteries constrict to increases in flow: role of 20-HETE and TP receptors | Q34187177 | ||
| The role of 20-HETE in androgen-mediated hypertension | Q34196923 | ||
| Trends in the exploitation of novel drug targets | Q34205159 | ||
| Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction | Q34243343 | ||
| Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects | Q34321476 | ||
| 2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor. | Q37624176 | ||
| Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling | Q37627060 | ||
| Sex and gender differences in cardiovascular drug therapy | Q38048668 | ||
| Regulated expression of the prostacyclin receptor (IP) gene by androgens within the vasculature: Combined role for androgens and serum cholesterol | Q38760544 | ||
| The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells. | Q38816699 | ||
| 2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male Mice | Q38833622 | ||
| Anti-fibrotic actions of relaxin. | Q38850557 | ||
| Sex-dependent effects of G protein-coupled estrogen receptor activity on outcome after ischemic stroke. | Q39265589 | ||
| Cardiomyocyte-specific deletion of the G protein-coupled estrogen receptor (GPER) leads to left ventricular dysfunction and adverse remodeling: A sex-specific gene profiling analysis | Q39304495 | ||
| Sex-biased eicosanoid biology: Impact for sex differences in inflammation and consequences for pharmacotherapy | Q39396429 | ||
| Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. | Q39900531 | ||
| Ovarian hormones modulate endothelin A and B receptor expression | Q40097867 | ||
| Altered pain perception and inflammatory response in mice lacking prostacyclin receptor | Q40646776 | ||
| Investigation of the mechanisms of G protein: effector coupling by the human and mouse prostacyclin receptors. Identification of critical species-dependent differences | Q40730973 | ||
| GPER is required for the age-dependent upregulation of the myocardial endothelin system | Q42359693 | ||
| 17beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase | Q42516727 | ||
| THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors | Q42660449 | ||
| THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes | Q42660454 | ||
| THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors. | Q42660482 | ||
| THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors | Q42660484 | ||
| Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries | Q43198450 | ||
| Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids | Q43560259 | ||
| Gender differences in the attenuation of salt-induced hypertension by angiotensin (1-7). | Q43628577 | ||
| Gender differences in vascular expression of endothelin and ET(A)/ET(B) receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension | Q44130182 | ||
| Sex differences in the antithrombotic effects of aspirin | Q44208803 | ||
| Gender differences in ET and NOS systems in ETB receptor-deficient rats: effect of a high salt diet | Q44353803 | ||
| Mechanisms of 17beta-estradiol on the production of ET-1 in ovariectomized rats | Q44588472 | ||
| Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). | Q44930351 | ||
| COX-2-derived prostacyclin confers atheroprotection on female mice | Q45154810 | ||
| The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation | Q45216542 | ||
| Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone. | Q34385562 | ||
| Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography–tandem mass spectrometry | Q34419912 | ||
| 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension. | Q34553783 | ||
| A comprehensive view of sex-specific issues related to cardiovascular disease | Q34577461 | ||
| Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors | Q34581803 | ||
| A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women | Q34635603 | ||
| G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol | Q34787653 | ||
| Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice | Q34849712 | ||
| Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. | Q34984856 | ||
| 20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptor | Q34999553 | ||
| 17 Beta-estradiol regulates the expression of endothelin receptor type B in the heart | Q35045657 | ||
| Sex differences in renal medullary endothelin receptor function in angiotensin II hypertensive rats | Q35120386 | ||
| Androgens and cardiovascular disease | Q35146318 | ||
| Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat | Q35216117 | ||
| High salt diet increases the pressor response to stress in female, but not male ETB-receptor-deficient rats | Q35363150 | ||
| Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780. | Q35447240 | ||
| Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity | Q35563456 | ||
| International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators | Q35795751 | ||
| Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats | Q35839121 | ||
| Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skövde Cohort | Q35843056 | ||
| GPER regulates endothelin-dependent vascular tone and intracellular calcium | Q35968858 | ||
| Gender differences in prostaglandin receptors of rat aorta | Q36127980 | ||
| ET-1 actions in the kidney: evidence for sex differences | Q36610325 | ||
| G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity. | Q36663052 | ||
| The Importance of Biological Sex and Estrogen in Rodent Models of Cardiovascular Health and Disease | Q36807388 | ||
| Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension | Q36877109 | ||
| Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females | Q36902613 | ||
| Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition | Q37089449 | ||
| Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen | Q37147084 | ||
| Sex differences in ET-1 receptor expression and Ca2+ signaling in the IMCD. | Q37234714 | ||
| Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. | Q37281123 | ||
| Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. | Q37339848 | ||
| Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity | Q37435268 | ||
| Physiology of endothelin and the kidney | Q37613679 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sexual dimorphism | Q181497 |
| P304 | page(s) | 4047-4059 | |
| P577 | publication date | 2018-03-25 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | GPCRs in context: sexual dimorphism in the cardiovascular system | |
| P478 | volume | 175 |
Search more.